Novartis Ag NVS
NYSE NVS
$140.35 -0.58 (-0.41%)
At close: Sep 18, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Income towards Parent Company (2009 - 2026)

Novartis Ag's (NVS) quarterly Income towards Parent Company came in at $3.3 billion in Q2 2026, down 19.23% year-over-year from $4.0 billion in Q2 2025, and down 27.82% quarter-over-quarter from $4.5 billion in Q1 2026.

Analysis

Novartis Ag (NVS) Income towards Parent Company (2009 - 2026) Analysis & Trends

Novartis Ag has disclosed Income towards Parent Company across 18 years of filings, most recently posting $3.3 billion for Q2 2026.

  • In Q2 2026, Income towards Parent Company fell 19.23% year-over-year to $3.3 billion; the TTM figure through Jun 2026 stood at $22.5 billion (down 7.91% YoY), while the FY2025 annual figure was $14.0 billion, up 17.11% from the prior year.
  • Income towards Parent Company came in at $3.3 billion for Q2 2026 at Novartis Ag, down from $4.5 billion in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $13.4 billion in Q4 2023 to a low of $1.7 billion in Q2 2022.
  • Average Income towards Parent Company over 5 years is $4.9 billion, with a median of $3.6 billion recorded in 2024.
  • Year-over-year, Income towards Parent Company sank 59.69% in 2022 and surged 94.73% in 2024.
  • Over 5 years, Income towards Parent Company stood at $7.2 billion in 2022, then soared by 85.16% to $13.4 billion in 2023, then declined by 13.5% to $11.6 billion in 2024, then decreased by 11.63% to $10.2 billion in 2025, then slumped by 68.13% to $3.3 billion in 2026.
  • Per Business Quant data, the three most recent Income towards Parent Company figures were $3.3 billion in Q2 2026, $4.5 billion in Q1 2026, and $10.2 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.26 Bn
Mar 31, 2026 4.52 Bn
Dec 31, 2025 10.24 Bn
Sep 30, 2025 4.46 Bn
Jun 30, 2025 4.04 Bn
Mar 31, 2025 5.21 Bn
Dec 31, 2024 11.59 Bn
Sep 30, 2024 3.59 Bn
Jun 30, 2024 3.25 Bn
Mar 31, 2024 3.57 Bn
Dec 31, 2023 13.40 Bn
Sep 30, 2023 1.84 Bn
Jun 30, 2023 2.32 Bn
Mar 31, 2023 3.03 Bn
Dec 31, 2022 7.24 Bn
Sep 30, 2022 2.09 Bn
Jun 30, 2022 1.69 Bn
Mar 31, 2022 3.12 Bn
Dec 31, 2021 17.95 Bn
Sep 30, 2021 3.70 Bn